ArticleJournal for immunotherapy of cancer2021

Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.

Georgia M Beasley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.